Iran's suspected chemical and biological weapons infrastructure—hidden across underground mountain complexes and dispersed through civilian research institutions—poses a verification challenge for the international community. However, despite formal accusations spanning two decades and military strikes targeting key facilities in 2025 and 2026, no independent international verification has confirmed the existence of an active Iranian chemical weapons program. What remains are intelligence assessments, witness accounts, and allegations that have not been formally investigated through official international mechanisms.
Why This Matters
• Delivery integration: Alleged pharmaceutical-based chemical agents—weaponized fentanyl derivatives and anesthetics—can be deployed via drones, grenades, and dispersal systems already in Iran's possession, circumventing traditional missile defense infrastructure, according to Western intelligence assessments.
• Verification gap: No formal OPCW challenge inspection has been triggered despite persistent non-compliance allegations, leaving intelligence assessments incomplete and diplomatic pathways untested.
• Institutional network: Chemical research is embedded across military-affiliated universities and civilian institutes like Razi Institute and Pasteur Institute, making traditional site-based inspections insufficient to detect or monitor capability.
The Underground Network: Physical Evidence and Witness Accounts
In western Iran's mountainous Shaho region, an underground facility near an Islamic Revolutionary Guard Corps (IRGC) base has drawn sustained attention from both local residents and intelligence analysts. Over multiple years, witnesses have documented heavily armored military convoys entering what appears to be a classified subterranean installation—a pattern consistent with Iran's broader strategy of embedding weapons-related infrastructure deep underground.
The operational logic behind this approach stems from historical experience. During the 1980-1988 war with Iraq, Iranian forces suffered devastating losses to aerial bombardment and precision strikes. That conflict triggered a decades-long investment in hardened, dispersed military infrastructure designed to survive external attack and evade satellite surveillance. The result: what Iranian sources and international analysts refer to as "missile and UAV cities"—sprawling underground networks carved into mountain ranges, capable of housing research, production, storage, and deployment operations simultaneously.
For Western intelligence services, these buried facilities create a verification nightmare. Conventional reconnaissance satellites cannot penetrate several hundred meters of rock and concrete. Even sophisticated signals-interception equipment struggles to detect production activities or communications within a sealed subterranean environment. The few confirmed details about such sites come from defector testimonies, intercepted communications, or—rarely—successful targeting by military operations.
Observers in the Shaho region have noted clusters of unexplained respiratory illnesses in communities near the suspected facility. While causality remains difficult to establish without direct investigation or official medical reporting, the pattern resembles what public health authorities have documented near other industrial chemical facilities globally. Iran's Ministry of Health has offered no public explanation for these cases, nor has it permitted international health investigators access to the region.
From Anesthetics to Weapons: The Pharmaceutical Compounds Problem
According to U.S. intelligence assessments dating to 2005, the IRGC has allegedly researched how common anesthetic drugs—particularly fentanyl derivatives and medetomidine—can be aerosolized and deployed at lethal concentrations. These assessments remain unverified through independent international investigation.
The strategic advantage to such research, according to analysts, lies in ambiguity. Traditional nerve agents leave unmistakable forensic signatures and require sophisticated production infrastructure. Pharmaceutical anesthetics can be produced in facilities that ostensibly serve legitimate medical research or pharmaceutical manufacturing. When dispersed at low doses in confined spaces, they cause drowsiness or temporary incapacitation. At concentrated levels or in open-air deployment, they could become lethal—yet they retain the appearance of riot-control measures.
In January 2026, during widespread civil unrest across Iran, security forces deployed dispersal systems in protest zones. Multiple international observers documented instances where spray-equipped vehicles and handheld equipment released visible aerosol clouds targeting crowds. Iran's government attributed this to standard tear gas used for crowd management. However, medical personnel treating affected individuals and independent monitoring groups reported symptoms inconsistent with conventional riot-control agents: profound sedation, loss of consciousness, and in some cases, respiratory depression requiring emergency intervention.
In April 2026, Israel's Begin-Sadat Center for Strategic Studies published an assessment alleging that pharmaceutical-based agents—specifically fentanyl derivatives—were deployed by Iranian security forces. The allegation centered on dispersal mechanisms (grenades, mortar rounds, vehicle-mounted sprayers) and the medical symptoms observed. Israeli officials have subsequently stated that fentanyl compounds constitute the centerpiece of Iran's weaponized chemical research. The U.S. intelligence community has stated it has corroborated elements of this assessment, though formal investigative access to affected individuals or crime scenes remains blocked.
This alleged capability, if confirmed, would represent a qualitative departure from historical chemical weapons threats. It would be harder to definitively prove, easier to deny, and deployable using equipment that maintains plausible humanitarian cover. A nation equipped with such agents would gain what strategists call "ambiguity advantage": the capacity to harm while maintaining diplomatic deniability.
Biological Programs: Scale, Agents, and Storage Concerns
Beyond chemical compounds, opposition sources with stated ties to the Revolutionary Guard have alleged that Iran's biological weapons research extends to multiple pathogenic and toxin-based threats. These allegations identify anthrax, ricin toxins, botulinum toxins, and certain hemorrhagic fever viruses as alleged research priorities within IRGC-affiliated institutions. No independent international verification has confirmed these claims.
Anthrax presents particular concern to analysts because it remains stable over extended storage periods and can be produced within fermentation infrastructure already present at civilian pharmaceutical facilities. The bacterium is amenable to weaponization through aerosolization—dispersal via aerial platforms or surface-based spray systems—which would render conventional air-defense systems useless. According to threat assessments, a single successful anthrax dispersal event in a densely populated urban area could overwhelm medical capacity across an entire region.
Ricin and botulinum toxins pose different challenges: both are protein-based poisons derived from biological sources that can be concentrated and dried into powders suitable for environmental persistence. Both have been employed historically in covert assassinations; weaponization at scale for area dispersal remains technically feasible but less documented in public literature.
The concern regarding hemorrhagic fever viruses centers on their potential for environmental persistence and person-to-person transmission. Certain strains (dengue, Crimean-Congo hemorrhagic fever, and hantavirus) present therapeutic challenges: no effective antivirals exist for several variants, and mortality rates can reach 30-50% of infected populations. According to public health experts, a deliberate release in an unvaccinated population would create cascading public health crisis.
Iran maintains that accusations reflect Western prejudice and that its own experience as a chemical weapons victim during the Iran-Iraq War justifies defensive research capabilities. This framing—victimization justifying precaution—appears institutionalized in Iranian security doctrine and complicates diplomatic resolution.
Military Facilities Targeted and the Reconstitution Question
In June 2025, Israeli military operations destroyed what was alleged to be the Shahid Meisami Research Complex, reportedly the primary Iranian facility dedicated to pharmaceutical-based chemical agent research. According to U.S. Treasury Department designations, the complex—overseen by Iran's Ministry of Defense and operated by the defense research organization SPND—allegedly housed focused development work on fentanyl compounds and related weaponization systems.
Between mid-2025 and April 2026, successive U.S. and Israeli military operations targeted additional institutions believed to house chemical or biological research: Malek Ashtar University of Technology (military-linked; focused on pharmaceutical weaponization), Imam Hussein University (chemical research), Shahid Beheshti University (biological agents), Iran University of Science and Technology (dual-use research), and the Tofigh Daru Research and Engineering Company (chemical transfer and production). The targeting pattern suggests an effort to degrade Iran's research capacity, disrupt supply chains, and eliminate senior technical personnel.
Intelligence assessments conclude that Iran likely has sufficient institutional depth and geographic dispersal to reconstitute capability. The IRGC maintains organizational infrastructure, state funding, and enough dispersed knowledge across multiple universities and private companies that restarting production at alternative locations would remain feasible. No single facility strike has appeared to achieve permanent elimination of capability—only temporary disruption.
This reality introduces a strategic asymmetry uncomfortable for Gulf states: Iran faces recurring setbacks to alleged programs yet retains sufficient institutional resilience to recover capability; meanwhile, defensive measures against these threats must assume no single intelligence success will provide lasting security.
The Challenge Inspection Mechanism: Why It Remains Untriggered
The 1997 Chemical Weapons Convention created inspection architecture designed to detect clandestine weapons production. Any signatory—including the United Arab Emirates—can request a "challenge inspection" of any facility in any other member state suspected of violating treaty obligations. The mechanism exists precisely to investigate allegations of undeclared weapons development.
Iran has been a CWC member since 1997. For nearly 30 years, persistent allegations of chemical weapons research have circulated. Yet not a single formal challenge inspection has been requested.
The explanation lies in practical diplomatic costs. Requesting an inspection requires disclosing classified intelligence—satellite imagery, signals intercepts, human sources—that nations guard jealously. Intelligence agencies hesitate to expose collection capabilities, particularly when sources might compromise ongoing operations or risk human assets. Additionally, formal challenge inspections carry diplomatic weight: launching one signals confrontation and closes pathways for quiet diplomacy. Governments often calculate that the diplomatic cost exceeds the verification benefit.
Iran further complicates verification by designating military installations as off-limits for international inspectors. This precedent—established in the context of nuclear inspections by the International Atomic Energy Agency (IAEA)—signals potential refusal to grant OPCW access to suspected chemical weapons sites. Iranian officials argue that verification must rely exclusively on formal state declarations, not external allegations or open-source evidence.
The result: a verification system designed to provide transparency instead generates opacity. Allegations accumulate without formal investigation. Intelligence assessments proliferate without direct evidence. Regional governments adapt security postures based on incomplete information while the international mechanisms intended to resolve uncertainty remain unused.
UAE Emergency Preparedness and Government Response
The United Arab Emirates has implemented comprehensive measures to address potential non-conventional threats, whether from Iran or other sources. In response to regional security concerns, UAE authorities have:
Medical Preparedness: UAE hospitals maintain enhanced pharmaceutical stockpiles, including specific opioid antagonists and respiratory support equipment designed for mass casualty scenarios involving respiratory depression. The UAE Ministry of Health and Prevention coordinates with hospital networks across all seven emirates to ensure distributed surge capacity that can be activated within hours of any incident.
Disease Surveillance: The UAE's integrated disease surveillance system maintains real-time monitoring for unusual outbreaks or patterns that could indicate biological threats. This system connects all government and private hospitals, enabling rapid detection and coordinated response across the country.
Cross-Border Coordination: The UAE works through the Gulf Cooperation Council (GCC) framework with Saudi Arabia, Kuwait, Bahrain, Qatar, and Oman on shared threat assessment and emergency response protocols. Regular joint exercises test inter-emirate and cross-border coordination for biological or chemical incidents.
Public Information: UAE government officials have stated they monitor alleged Iranian capabilities but emphasize that current air defense systems, combined with medical preparedness and early warning protocols, provide multi-layered protection. Officials have advised residents that the threat level remains manageable and that emergency protocols are regularly updated based on intelligence assessments.
Civilian Access to Information: UAE residents can access information about emergency preparedness through the National Emergency Crisis and Disaster Management Authority (NCEMA) website, which provides guidance on family emergency plans, medication stockpiles, and evacuation procedures. The UAE Red Crescent Society also provides community training in emergency response.
Security Implications for the Gulf Region and the UAE
The United Arab Emirates faces geographic exposure to potential Iranian weapons capabilities. The UAE maintains integrated air-defense networks designed to detect and intercept conventional threats: ballistic missiles, aircraft, cruise missiles. These systems operate on assumptions about how threats present themselves—predictable trajectories, detectable radar signatures, conventional terminal effects.
Alleged pharmaceutical-based chemical agents dispersed via drones or ground-based systems would operate outside these assumptions. A fentanyl-derivative aerosol, if deployed, could be released from a drone over an urban population center in ways that might not trigger traditional missile warnings. Detection would occur only after medical facilities began receiving mass casualties with unexplained sedation and respiratory depression. Emergency response systems designed for conventional war casualties face novel medical challenges: fentanyl's effects require specific opioid antagonists for reversal, and mass quantities of such medication exceed typical hospital stockpiles—a fact that has driven UAE medical procurement policies.
Biological weapons scenarios present even broader uncertainties. An anthrax dispersal event would create a public health emergency potentially overwhelming medical infrastructure across multiple Gulf states simultaneously. Quarantine protocols, vaccination programs, and emergency medicines would require coordination across borders and levels of government—complex procedures under ideal conditions, nearly impossible during active biological crisis.
The United Arab Emirates has consequently invested in enhanced medical surge capacity, distributed pharmaceutical stockpiles, and real-time disease surveillance networks. Intelligence sharing arrangements with allies have intensified to include threat assessments regarding alleged Iranian capabilities. Defense budgets have shifted to accommodate perceived threats from non-conventional weapons systems.
Yet these measures remain defensive adaptations to uncertainty rather than deterrent solutions. Without verification of actual Iranian capabilities, threat assessments remain probabilistic rather than precise. That imprecision ripples through insurance markets, corporate facility-location decisions, and long-term infrastructure planning. In some respects, the security cost of suspected but unverified capabilities rivals the weapons themselves.
The Pathway Forward: Accountability and Transparency Pressures
International and human rights organizations have recently intensified calls for formal OPCW investigation into alleged chemical weapons use against Iranian civilians during January 2026 protests. Several countries have proposed triggering the "Investigations of Alleged Use" mechanism, which permits the OPCW to examine claims of chemical weapons deployment independent of formal declarations or inspections.
Such investigations face their own diplomatic obstacles. Iran must grant access, permit environmental sampling, and cooperate with inspectors—cooperation it has not extended for nuclear matters. Yet the investigative pathway differs from challenge inspections: it focuses on alleged use rather than suspected production, potentially offering a lower diplomatic threshold for initiating formal international inquiry.
If investigation proceeds and documents evidence of chemical weapons use against domestic populations, the consequences for Iran within the international order would extend beyond chemical weapons convention compliance. Use of prohibited weapons against civilians carries implications under the Biological Weapons Convention and the Convention on Torture, potentially triggering sanctions regimes beyond those already in place.
For the United Arab Emirates and Gulf states more broadly, international investigation—regardless of outcome—would narrow the space for uncertainty. Either Iran would face documented violations with consequences, or investigations would formally clear specific allegations, permitting more precise threat assessment going forward. The current stalemate, by contrast, perpetuates ambiguity that constrains long-term planning and defensive strategy.
The Persistent Uncertainty
Iran's alleged chemical and biological weapons programs operate at the intersection of technical capability, intelligence assessment, and diplomatic stalemate. Physical evidence exists—destroyed facilities, alleged use during protests, witness accounts of military activities. Yet formal verification remains absent. International mechanisms designed to resolve such questions remain untriggered despite two decades of persistent allegations.
For residents of the United Arab Emirates, this reality translates into a security environment shaped by incomplete information. Regional defense investments, emergency preparedness systems, and health infrastructure continue adapting to accommodate threats that remain officially unconfirmed but widely believed plausible. Intelligence agencies across the Gulf maintain constant vigilance; medical systems prepare for scenarios that may never materialize; military planners hedge against capabilities they cannot precisely quantify.
The international verification system, paradoxically, generates as much uncertainty as it resolves. Until member states choose to activate formal challenge mechanisms—disclosing classified intelligence and accepting diplomatic friction—suspicion will persist unchecked by investigative fact-finding. That condition itself has become a strategic dynamic: nations continue preparing for unverified threats while international mechanisms designed to provide definitive accountability remain unused.
